Cargando…
Treatment of hemophilia: a review of current advances and ongoing issues
Replacement of the congenitally deficient factor VIII or IX through plasma-derived or recombinant concentrates is the mainstay of treatment for hemophilia. Concentrate infusions when hemorrhages occur typically in joint and muscles (on-demand treatment) is able to resolve bleeding, but does not prev...
Autores principales: | Coppola, Antonio, Di Capua, Mirko, Di Minno, Matteo Nicola Dario, Di Palo, Mariagiovanna, Marrone, Emiliana, Ieranò, Paola, Arturo, Claudia, Tufano, Antonella, Cerbone, Anna Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262316/ https://www.ncbi.nlm.nih.gov/pubmed/22282697 http://dx.doi.org/10.2147/JBM.S6885 |
Ejemplares similares
-
Mesoglycan: Clinical Evidences for Use in Vascular Diseases
por: Tufano, Antonella, et al.
Publicado: (2010) -
Diabetes Mellitus and Cardiovascular Prevention: The Role and the Limitations of Currently Available Antiplatelet Drugs
por: Tufano, A., et al.
Publicado: (2011) -
Acquired Hemophilia A Successfully Treated with Rituximab
por: D’Arena, Giovanni, et al.
Publicado: (2015) -
Acquired Haemophilia A in the Elderly: Case Reports
por: Tufano, Antonella, et al.
Publicado: (2010) -
The Arrival of Gene Therapy for Patients with Hemophilia A
por: Castaman, Giancarlo, et al.
Publicado: (2022)